287 related articles for article (PubMed ID: 31990892)
1. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
Wiegand S; Dietz A; Wichmann G
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
Saibene AM; Rosso C; Felisati G; Pignataro L; Schindler A; Ghilardi G; Colletti G; Gaffuri M; Mozzanica F
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3529-3540. PubMed ID: 37115326
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
[TBL] [Abstract][Full Text] [Related]
5. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
6. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
Wiegand S; Wichmann G; Dietz A
Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus for the treatment of children with various complicated vascular anomalies.
Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
[TBL] [Abstract][Full Text] [Related]
8. Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
Zobel MJ; Nowicki D; Gomez G; Lee J; Howell L; Miller J; Zeinati C; Anselmo DM
J Pediatr Surg; 2021 May; 56(5):1062-1067. PubMed ID: 33982660
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
10. Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations.
Alemi AS; Rosbe KW; Chan DK; Meyer AK
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2466-9. PubMed ID: 26549380
[TBL] [Abstract][Full Text] [Related]
11. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations.
Geeurickx M; Labarque V
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1321-1333. PubMed ID: 33737259
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
[TBL] [Abstract][Full Text] [Related]
13. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306
[TBL] [Abstract][Full Text] [Related]
14. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
Gómez Sánchez A; Redondo Sedano JV; Pérez Alonso V; Martí Carrera ME; Baro Fernández M; Palencia Pérez SI; Gallego Herrero MC; Gómez Fraile A; Delgado Muñoz MD
Cir Pediatr; 2020 Oct; 33(4):183-187. PubMed ID: 33016658
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
16. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
[TBL] [Abstract][Full Text] [Related]
17. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
Kim D; Benjamin L; Wysong A; Hovsepian D; Teng J
Dermatol Ther; 2015; 28(4):218-21. PubMed ID: 25753853
[TBL] [Abstract][Full Text] [Related]
18. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
20. Microcystic Lymphatic Malformation Successfully Treated With Topical Rapamycin.
García-Montero P; Del Boz J; Sanchez-Martínez M; Escudero Santos IM; Baselga E
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]